Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

AVI Biopharma offers oncology products for licensing

June 16, 1998

Spartaject busulfan enters phase I for treatment of neoplastic meningitis

June 15, 1998

Novartis selects somatostatin receptor-targeting antitumor compound for clinical testing

June 15, 1998

NeoPharm announces positive phase I clinical trial results with LED

June 15, 1998

Abarelix: a promising new treatment option for patients with prostate cancer

June 12, 1998

More on Ilex Oncology's chemopreventive agent

June 11, 1998

Duke University pioneers novel therapy for GBM

June 11, 1998

Vapreotide, RC-3940-II and cetrorelix: novel peptide analogues for treating renal cell carcinoma

June 11, 1998

Miravant and Xillix Technologies enter early-stage cancer collaboration

June 10, 1998

GlycoDesign starts phase II trial of GD0039 for the treatment of RCC

June 10, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...